Total Payments
$7,064
2024 Payments
$1,427
Companies
40
Transactions
367
Medicare Patients
10,745
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$6,531 (92.5%)
Education$532.96 (7.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,531 | 360 | 92.5% |
| Education | $532.96 | 7 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $906.46 | 45 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $771.62 | 28 | $0 (2024) |
| ABBVIE INC. | $710.86 | 60 | $0 (2024) |
| Lilly USA, LLC | $706.22 | 36 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $505.28 | 30 | $0 (2024) |
| Celgene Corporation | $411.10 | 14 | $0 (2024) |
| PFIZER INC. | $393.13 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $387.35 | 18 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $253.80 | 16 | $0 (2024) |
| ARGENX US, INC. | $193.10 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,427 | 60 | Alexion Pharmaceuticals, Inc. ($255.92) |
| 2023 | $1,747 | 87 | AbbVie Inc. ($292.30) |
| 2022 | $1,727 | 96 | Biogen, Inc. ($309.27) |
| 2021 | $815.25 | 49 | Biogen, Inc. ($274.72) |
| 2020 | $276.31 | 15 | Lilly USA, LLC ($84.17) |
| 2019 | $270.93 | 16 | Biogen, Inc. ($59.63) |
| 2018 | $433.94 | 23 | Teva Pharmaceuticals USA, Inc. ($202.65) |
| 2017 | $366.91 | 21 | Purdue Pharma L.P. ($105.67) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Diagnostic Tracer | ||||||
| 12/16/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.18 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: EPILEPSY | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $58.83 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/11/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | Curium US LLC | Detectnet (Drug) | Food and Beverage | Cash or cash equivalent | $22.48 | General |
| Category: Radioactive diagnostic agent | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Neurology | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $119.70 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Rare Disease | ||||||
| 09/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: PAIN | ||||||
| 09/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Rare Disease | ||||||
| 08/27/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,047 | 3,947 | $539,175 | $237,873 |
| 2022 | 39 | 2,548 | 15,817 | $731,770 | $340,733 |
| 2021 | 40 | 3,205 | 21,929 | $937,826 | $454,478 |
| 2020 | 41 | 2,945 | 11,365 | $822,780 | $379,289 |
Total Patients
10,745
Total Services
53,058
Medicare Billing
$1.4M
Procedure Codes
160
All Medicare Procedures & Services
160 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 469 | $88,603 | $42,363 | 47.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 52 | 55 | $60,992 | $25,584 | 41.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 57 | 92 | $42,541 | $16,873 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 142 | 142 | $50,640 | $16,517 | 32.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 91 | 166 | $30,376 | $12,878 | 42.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 116 | 198 | $22,800 | $12,390 | 54.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 33 | 34 | $16,999 | $9,372 | 55.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 36 | 47 | $20,511 | $9,188 | 44.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 88 | $17,483 | $9,058 | 51.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 28 | 34 | $21,372 | $7,817 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 111 | $13,714 | $7,090 | 51.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 112 | 170 | $12,162 | $6,704 | 55.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 36 | 58 | $14,341 | $5,859 | 40.9% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 48 | 59 | $11,815 | $5,328 | 45.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 36 | 36 | $11,122 | $5,093 | 45.8% |
| 62328 | Removal of spinal fluid with lower back spinal tap for diagnostic test using imaging guidance | Office | 2023 | 20 | 21 | $8,669 | $3,966 | 45.8% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 40 | 40 | $7,647 | $3,576 | 46.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $6,558 | $2,993 | 45.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 31 | $5,230 | $2,945 | 56.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $5,413 | $2,942 | 54.4% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 64 | 73 | $10,242 | $2,910 | 28.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 14 | 14 | $5,750 | $2,895 | 50.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 47 | 56 | $7,986 | $2,775 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 26 | 26 | $5,284 | $2,766 | 52.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 16 | $6,272 | $2,723 | 43.4% |
About Dr. Dennis Dey, MD
Dr. Dennis Dey, MD is a Pain Medicine healthcare provider based in Cumberland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972546364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dennis Dey, MD has received a total of $7,064 in payments from pharmaceutical and medical device companies, with $1,427 received in 2024. These payments were reported across 367 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,531).
As a Medicare-enrolled provider, Dey has provided services to 10,745 Medicare beneficiaries, totaling 53,058 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 160 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Neurology
- Location Cumberland, MD
- Active Since 06/14/2006
- Last Updated 12/10/2020
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972546364
Products in Payments
- TYSABRI (Biological) $656.92
- RYTARY (Drug) $539.69
- EMGALITY (Drug) $523.78
- ULTOMIRIS (Biological) $482.64
- ZEPOSIA (Drug) $411.10
- NURTEC ODT (Drug) $374.72
- UBRELVY (Drug) $343.15
- QULIPTA (Drug) $341.13
- KESIMPTA (Drug) $172.11
- VYVGART (Drug) $150.29
- RADICAVA (Drug) $144.32
- VYEPTI (Biological) $143.88
- AVONEX (Biological) $132.06
- Leqembi (Drug) $118.44
- Aimovig (Biological) $115.05
- KISUNLA (Drug) $113.34
- Soliris (Drug) $97.05
- ADUHELM (Biological) $95.99
- AUSTEDO (Drug) $88.15
- LYRICA (Drug) $88.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.